Host and Pathogen Factors forClostridium difficileInfection and Colonization

Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection

(2010) Michael D. Howell   ARCHIVES OF INTERNAL MEDICINE

Health Care–AssociatedClostridium difficileInfection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality

(2009) Mark Miller et al.   CLINICAL INFECTIOUS DISEASES

New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration

(2009) Michelle M. Merrigan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Toxin B is essential for virulence of Clostridium difficile

(2009) Dena Lyras et al.   NATURE

Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)

(2009) Brett A. Leav et al.   VACCINE

Characterization of Clostridium difficile Strains Isolated from Patients in Ontario, Canada, from 2004 to 2006

(2008) H. Martin et al.   JOURNAL OF CLINICAL MICROBIOLOGY